A genetic approach to mapping the p53 binding site in the MDM2 protein

Molecular Medicine

Volumn 3, Issue 4, 1997, Pages 248-259

  Freedman, Deborah A ^a   Epstein, Charles B ^a,b   Roth, Judith C ^a,c   Levine, Arnold J ^a  

^a PRINCETON UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN P53;

ARTICLE; BINDING SITE; GENE MAPPING; GENETIC ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SITE DIRECTED MUTAGENESIS;

EID: 0030981049     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401678     Document Type: Article

References (34)

1. Cahilly-Snyder L, Yang-Feng T, Francke U, George DL. (1987) Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Somat. Cell Mol. Gen. 13:235-244.
2. Fakharzadeh SS, Trusko SP, George DL. (1991) Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J. 10:1565-1569.
3. Finlay CA. (1993) The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth. Mol. Cell. Biol. 13: 301-306.
4. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. (1992) Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358:80-83.
5. Bueso-Ramos CE, Yang Y, deLeon E, McCown P, Stass SA, Albitar M. (1993) The human MDM-2 oncogene is overexpressed in leukemias. Blood 82:2617-2623.
6. Ladanyi M, Cha C, Lewis R, Jhanwar SC, Huvos AG, Healey JH. (1993) MDM2 gene amplification in metastatic osteosarcoma. Cancer Res. 53:16-18.
7. Leach FS, Tokino T, Meltzer P, et al. (1993) p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res. 53:2231-2234.
8. Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP. (1993) Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res. 53:2736-2739.
9. Sheikh MS, Shao Z-M, Hussain A, Fontana JA. (1993) The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma. Cancer Res. 53:3226-3228.
10. Cordon-Cardo C, Latres E, Drobnjak M, et al. (1994) Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res. 54:794-799.
11. Matsumura T, Yoshihama Y, Kimura T, Shintani S, Alcalde RE. (1996) p53 and MDM2 expression in oral squamous cell carcinoma. Oncology 53:308-312.
12. Watanabe T, Hotta T, Ichikawa A, et al. (1994) The MDM2 oncogens overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin. Blood 84: 3158-3165.
13. Landers JE, Haines DS, Strauss JF, George DL. (1994) Enhanced translation: A novel mechanism of mdm2 oncogene overexpression identified in human tumor cells. Oncogene 9:2745-2750.
14. Picksley SM, Spicer JF, Barnes DM, Lane DP. (1996) The p53-MDM2 interaction in a cancer-prone family, and the identification of a novel therapeutic target. Acta Oncologica 35: 429-434.
15. Momand J, Zambetti GP, Olson, DC, George D, Levine AJ. (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245.
16. Chen J, Lin J, Levine AJ. (1995) Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene. Mol. Med. 1:142-152.
17. 1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol. Cell. Biol. 16:2445-2452.
18. Ko LJ, Prives C. (1996) p53: Puzzle and paradigm. Genes Dev. 10:1054-1072.
19. Montes de Oca Luna R, Wagner DS, Lozano G. (1995) Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378:203-206.
20. Jones SN, Roe AE, Donehower LA, Bradley A. (1995) Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378:206-208.
21. Wu X, Bayle JH, Olson D, Levine AJ. (1993) The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7:1126-1132.
22. Perry ME, Piette J, Zawadzki JA, Harvey D, Levine AJ. (1993) The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc. Natl. Acad. Sci. U.S.A. 90:11623-11627.
23. Chen J, Marechal V, Levine AJ. (1993) Mapping of the p53 and mdm-2 interaction domains. Mol. Cell. Biol. 13:4107-4114.
24. Marechal V, Elenbaas B, Taneyhill L, et al. (1997) Conservation of structural domains and biochemical activities of the MDM2 protein from Xenopus laevis. Oncogene 14:1427-1433.
25. Marechal V, Elenbaas B, Piette J, Nicolas J-C, Levine AJ. (1994) The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol. Cell. Biol. 14:7414-7420.
26. Boddy MN, Freemont PS, Borden KLB. (1994) The p53-associated protein MDM2 contains a newly characterized zinc-binding domain called the RING finger. Trends Biochem. Sci. 19:198-199.
27. Elenbaas B, Dobbelstein M, Roth J, Shenk T, Levine AJ. (1996) The MDM2 oncoprotein binds specifically to RNA through its RING finger domain. Mol. Med. 2:439-451.
28. Xiao Z-X, Chen J, Levine AJ, et al. (1995) Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375:694-698.
29. Martin K, Trouche D, Hagemeier C, Sorensen TS, La Thangue NB, Kouzarides T. (1995) Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 375:691-694.
30. Kussie PH, Gorina S, Marechal V, et al. (1996) Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274:948-953.
31. Gyuris J, Golemis E, Chertkov H, Brent R. (1993) Cdil, a human G1- and S-phase protein phosphatase that associates with Cdk2. Cell 75:791-803.
32. Sikorski RS, Hieter P. (1989) A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122:19-27.
33. Rose M, Winston F, Hieter P. (1990) Methods in Yeast Genetics: A Laboratory Course Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
34. Lin J, Chen J, Elenbaas B, Levine AJ. (1994) Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev. 8:1235-1246.